Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brief report on Ziprasidone.

A H M Firoz1, A H M M Rahman, W A Chowdhury

  • 1National Institute of Mental Health Sher-E-Bangla Nagar, Dhaka.

Mymensingh Medical Journal : MMJ
|October 25, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dietary inclusion of Moringa oleifera: Impacts on egg production, egg quality with fatty acid, amino acid profiling and serum immunity of laying hens.

Poultry science·2026
Same author

Assessment of the Quality Assurance Scheme of Government Medical Colleges of Mymensingh Division.

Mymensingh medical journal : MMJ·2025
Same author

Stroke incidence, trends, and geographic disparities in Ghana: An analysis of nationwide health facility records.

Public health·2025
Same author

Role of IRF4-Mediated Inflammation: Implication in Neurodegenerative Diseases.

Neurology & neurotherapy open access journal·2024
Same author

An Alarming Rise of Candidemia Caused by Non-Albicans Candida Species in Intensive Care Unit in Mymensingh, Bangladesh.

Mymensingh medical journal : MMJ·2024
Same author

Antimicrobial Susceptibility Patterns of Bacterial Isolates from Blood Culture of Pediatric Patients with Suspected Sepsis at a Tertiary Care Hospital in Mymensingh, Bangladesh.

Mymensingh medical journal : MMJ·2024

Ziprasidone, an antipsychotic with dopamine and serotonin activity, effectively treats schizophrenia and schizo-affective disorder. It offers benefits for negative and depressive symptoms with fewer side effects than older drugs.

Area of Science:

  • Pharmacology
  • Psychiatry
  • Neuroscience

Background:

  • Ziprasidone is a novel antipsychotic agent.
  • It exhibits combined dopamine and serotonin receptor antagonist activity.
  • Current evidence suggests an effective dosage range of 80-160 mg/day.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of ziprasidone.
  • To assess its effects on positive, negative, and affective symptoms in schizophrenia and schizo-affective disorder.
  • To compare its side effect profile with conventional antipsychotics.

Main Methods:

  • Clinical trials were conducted to assess ziprasidone's effectiveness.
  • Data on adverse effects were collected and analyzed.
  • Efficacy was evaluated for various symptom domains.

Related Experiment Videos

Main Results:

  • Ziprasidone demonstrated efficacy in treating schizophrenia and schizo-affective disorder.
  • The drug showed beneficial effects on negative symptoms and depression.
  • Common adverse effects included somnolence (14%) and nausea (10%).

Conclusions:

  • Ziprasidone presents a favorable efficacy and tolerability profile.
  • Its combined dopaminergic and serotonergic actions enhance treatment for negative and affective symptoms.
  • Ziprasidone offers an attractive alternative to conventional antipsychotics due to potentially reduced cognitive side effects.